GENCOVERY

Gencovery was founded in 2020. Its vision is to democratize access to artificial intelligence and data in biotechnology in order to provide an efficient and pragmatic response to a major challenge in this field, which is "the digital transformation, acceleration and sustainability of R&D”. The company started from the observation that despite the emergence of big data over the past 20 years, over 90% of scientists cannot efficiently harness data. Existing solutions are difficult to access, specific, non-scalable, and therefore poorly suited to R&D.

Gencovery is therefore specialized in the digitization of complex R&D projects in the biotech and pharma industry in order to provide an innovative solution, respond to this problem and initiate the era of "industry 4.0". The company has therefore just launched its collaborative software platform Constellab™, which enables the end-to-end digitization of a company's entire value chain in order to connect data and expertise, simplify their processes, accelerate and sustain the R&D.

Constellab™ and its collaborative vision have already convinced players in the national ecosystem (SMEs and major biotech groups, universities, major schools).

Gencovery wants to raise €2 million (dilutive €1 million) in order to accelerate the dissemination of its solution to be the leader in its field by 2026.